Helicobacter pylori is a dominant bacterium living in the human gastric tissues. In H. pylori-infected tissues, the infiltrated inflammatory cells produce reactive oxygen species (ROS), leading to gastric inflammation with production of various mediators. According to numerous epidemiological studies, dietary carotenoids may prevent gastric inflammation due to their antioxidant properties. Recent studies showed that antioxidant and anti-inflammatory effects of astaxanthin and -carotene may contribute to inhibition of H. pylori-induced gastric inflammation. Astaxanthin changes H. pylori-induced activation of T helper cell type 1 response towards T helper cell type 2 response in the infected tissues. Astaxanthin inhibits the growth of H. pylori. Even though astaxanthin reduces H. pylori-induced gastric inflammation, it does not reduce cytokine levels in the infected tissues. -Carotene suppresses ROS-mediated inflammatory signaling, including mitogen-activated protein kinases and redox-sensitive transcription factors, and reduces expression of inflammatory mediators, including interleukin-8, inducible nitric oxide synthase, and cyclooxygenase-2 in the infected tissues. Therefore, consumption of astaxanthin-and -carotene-rich foods may be beneficial to prevent H. pylori-induced gastric inflammation. This review will summarize anti-inflammatory mechanisms of astaxanthin and -carotene in H. pylori-mediated gastric inflammation. 
INTRODUCTION
Helicobacter pylori is a Gram-negative and microaerophilic bacterium which has been considered as one of major pathogenetic factors for peptic ulcer disease and gastric cancer.
1,2 H. pylori stimulates production of reactive oxygen species (ROS), leading to expression of inflammatory mediators as well as imbalance of the apoptotic and proliferative process in the infected tissues. 3, 4 Oxidative damage indices such as lipid peroxides were higher in gastric mucosa of H. pylori-infected patients compared to the uninfected patients. 5 Once H. pylori attaches to host cells, the infiltrated inflammatory cells produce ROS. In addition, H. pyori induces activation of NADPH oxidase, which results in ROS production and activates redox-sensitive signal transduction via NF-B, activator protein-1 (AP-1), and mitogen activated protein kinases (MAPKs) to induce inflammatory proteins, including interleukin (IL)-8, COX-2, inducible nitric oxide synthase (iNOS), and intercellular adhesion molecule 1 in the infected cells. [6] [7] [8] [9] [10] [11] [12] [13] [14] Therefore, scavenging ROS by antioxidants may prevent oxidant-mediated inflammation in H. pylori-infected gastric mucosa.
Carotenoids are naturally occurring pigments synthesized by plants, algae, and photosynthetic bacteria. Depending on the presence of oxygen, the carotenoids have been divided into two groups, carotenes and xanthophylls. While the former does not contain oxygen, the latter contains oxygen. Nutritionally, the carotenoids are also grouped into pro-vitamin A and nonpro-vitamin A depending on their properties for conversion into vitamin A (retinol) in the intestine or liver. Carotenoids show antioxidant activities due to their conjugated double bonds. In addition, carotenoids affect cell cycle progression, gap junctional intercellular communication, growth factor signaling, and immune function. 15 A recent review showed that beneficial effects of carotenoid-rich vegetables and fruits in health and in decreasing the risk of cancers, cardiovascular disorders, and eye diseases have been attributed to the antioxidant effects of the major carotenoids, -carotene, lycopene, lutein, and zeaxanthin. 16 Dietary supplementation of carotenoids may reduce the risk of inflammatory diseases since oxidative stress activates inflammatory signaling pathways. Even though carotenoids have antioxidant action, the exact action mechanisms of carotenoids are still unclear. Among carotenoids, astaxanthin and -carotene show anti-inflammatory effects in gastric mucosa infected with H. pylori. In this review, we will discuss the mechanism by which astaxanthin and -carotene suppress H. pylori-induced gastric inflammation.
ASTAXANTHIN
Astaxanthin is a carotenoid found in high concentrations in the microalga Haematococcus pluvialis. 17 Astaxanthin occurs naturally in microalgae, fungi, complex plant, and crustaceans. 18 It acts as a powerful chain-breaking antioxidant by quenching single-and 2-electron oxidants and, thus, inhibits lipid peroxidation and oxidative DNA damage of the cells. [19] [20] [21] [22] Astaxanthin is the most effective immune stimulator among carotenoids. [23] [24] [25] It stimulates antibody production to T-dependent antigens and T-helper cell activity. 23, 24 Astaxanthin-rich algal meal inhibited colonization of H. pylori and reduced inflammation in the infected gastric tissues of BALB/cA mice. The mice treated with astaxanthin showed lower lipid peroxidation than those received with control diet. 26 Moreover, astaxanthin inhibited H. pylori growth and reduced bacterial load in the infected cells. 26 Supplementation of algal cell extract diet, which contains astaxanthin, reduced bacterial load and gastric inflammation of H. pylori-infected mice. 27 T-lymphocyte response of H. pylori-infected mice was different between astaxanthin-treated group and untreated group. H. pylori induced a predominant T helper cell type (Th) 1 response and release of interferon (IFN)-, which was changed to a Th2 response and release of IL-4 by astaxanthin treatment.
Dietary cell extract of Chlorococcum sp., which includes astaxanthin, reduced the bacterial load and modulated cytokine production in H. pylori-infected BALB/c mice. 28 Andersen et al. 29 studied gastric inflammatory markers and ILs (IL-4, IL-6, IL-8, IL-10, IFN-) in patients with functional dyspepsia treated with astaxanthin. There was a significant up-regulation of T helper cell (cluster of differentiation 4, CD4) and down-regulation of cytotoxic T cell (cluster of differentiation 8, CD8) in patients with H. pylori treated with astaxanthin. However, bacterial load and cytokine levels in the infected tissues were not affected by astaxanthin treatment. Since astaxanthin has antioxidant activity, further study should be performed to determine whether astaxanthin inhibits ROS-mediated inflammatory signaling in H. pylori-mediated gastric inflammation.
-CAROTENE
-carotene is abundant in orange-colored fruits and vegetables.
It is a non-enzymatic and chain breaking antioxidant. 30 -Carotene prevented the development of inflammatory disorders, including atherosclerosis and rheumatoid arthritis, by inhibiting oxidative stress-induced inflammatory signaling and tissue damage. [31] [32] [33] -Carotene acts as a quencher of radicals. -Carotene consists of 40-carbon basal structure, including conjugated double bonds, which determines its potential chemical and biological functions. 34 The abilities of -carotene to absorb light energy and to influence the antioxidant activity are mainly from the conjugated double bonds. 35 -carotene scavenges peroxyl radicals, which disturbs the reaction sequence leading to the damage. 36 IL-8 mediates inflammation by recruiting neutrophils and monocytes to the infected tissues. Expression of IL-8 is regulated by NF-B, a redox-sensitive transcription factors, in the inflammatory event. 37 We previously showed that -carotene inhibited NF-B activation and thus suppressed the expression of IL-8 in gastric epithelial cells. 38 -Carotene inhibited the induction of iNOS and COX-2 by blocking inflammatory signaling mediated by MAPKs, NF-B, and AP-1 in gastric epithelial cells. 39 Large amount of NO produced by iNOS contributes to gastric damage by generating peroxynitrite, a reaction product of NO and superoxide. Therefore, -carotene prevents oxidative stress-mediated tissue damage. Epidemiologic studies demonstrated that the mean serum levels of -carotene, folate, and retinol were lower in H. pylori-infected individuals than uninfected individuals. 40 This study suggests that H. pylori may reduce absorption of -carotene, folate, and retinol. Other study showed that low plasma levels of -carotene were associated with atrophic gastritis of H. pylori-infected patients. 41 In epidemiologic studies to verify the relationship between serum carotenoids and atrophic gastritis, there was inverse relation between intake of foods rich in carotenoids with pro-vitamin A and the risk of atrophic gastritis. 42 Feeding a diet supplemented with antioxidants reduced growth of H. pylori and gastritis in the stomach of guinea pigs. 43 This study suggests that a combination of antioxidants including carotenoids may be beneficial for treating H. pylori-mediated gastric inflammation. H. pylori-infected patients had lower -carotene level in gastric juice than uninfected patients. 44 In chronic H. pylori infection, bacteria modify the secretion of hydrochloric acid to increase pH, which impairs the absorption of -carotene. 45 In addition, low level of -carotene in gastric mucosal tissues was related to the presence of gastric atrophy and intestinal metaplasia. Taken together, gastric acidity may be an important factor for evaluating blood response curves to -carotene. Action mechanisms of -carotene could be summarized as follows. -Carotene reduces ROS levels and inactivates NF-B and AP-1 as well as inflammatory signaling including MAPKs, which inhibits expression of inflammatory mediators, such as IL-8, iNOS, and COX-2, in H. pylori-infected gastric tissues. 
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